Pantherx Specialty, LLC

Pittsburgh, PA Doing business as Pantherx Specialty Pharmacy

UEI
EG8MVF1BJ9H6
CAGE
82BT8
Primary NAICS
456110 Pharmacies and Drug Retailers
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Limited Liability Company
Entity structure
Partnership or Limited Liability Partnership
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
121 Bayer Rd Bldg 5, Pittsburgh, PA 15205, USA
Website
pantherxrare.com
Founded
2011
Employees
51-250
Estimated annual revenue
$10M-$50M
Industry
  1. Health Care
  2. Health Care Equipment & Services
  3. Health Care Providers & Services
  4. Health & Wellness
SIC code
59 Miscellaneous Retail
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Pantherx Specialty, LLC's 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Yorvipath medication for inmates Contract · 15B10626P00000346 Federal Correctional Complex Butner $32,331
B1 - pantherx - crenessity Contract · 15B41226P00000185 Federal Medical Center Rochester $58,927
B1 - pantherx - crenessity Contract · 15B41226P00000192 Federal Medical Center Rochester $58,927
Yorvipath medication for inmates Contract · 15B10626P00000339 Federal Correctional Complex Butner $16,166
B1 - pantherx - crenessity JUL 26 Contract · 15B41226P00000167 Federal Medical Center Rochester $58,927

About Pantherx Specialty, LLC

Pantherx Specialty, LLC, doing business as Pantherx Specialty Pharmacy, supplies specialty pharmaceutical products—including rare disease medications and emergency prescription drugs—to federal healthcare agencies as a prime contractor, with 100 percent of recent awards issued as purchase orders without small business set-asides. The company is a for-profit limited liability company and a subsidiary of Centene Corporation, headquartered in Pittsburgh, Pennsylvania, and operates a registered specialty pharmacy serving federal prison and Veterans Affairs medical facilities with difficult-to-source and customized medications.

The vendor's customer base concentrates heavily on two federal agencies that account for 100 percent of awards by count. The Department of Veterans Affairs Veterans Health Administration, primarily through Veterans Integrated Service Network 2, placed 28 awards valued at $297 thousand combined potential value; the Department of Justice Bureau of Prisons Federal Medical Center Rochester placed 11 awards valued at $483 thousand combined potential value. By dollar magnitude, Federal Medical Center Rochester leads with $483 thousand across eleven awards, followed by Veterans Integrated Service Network 16 with five awards valued at $443 thousand. All five customer agencies (VA VHA VISN 2, Federal Medical Center Rochester, VA VHA VISN 16, Federal Correctional Complex Butner, and VA VHA VISN 22) operate exclusively as direct purchasers of pharmaceutical supply; the source identifies no parent IDIQs, GWACs, or BPAs. Recent named awards include a $60 thousand firm fixed-price purchase order from Federal Medical Center Rochester for Crenessity medication issued July 1, 2026; a $16,165.62 order from Federal Correctional Complex Butner for Yorvipath medication dated June 22, 2026; and a $30,275.65 order from VA VHA VISN 22 for emergency Mavorixafor dated September 16, 2025. Drugs and Biologicals (PSC) accounts for 47 awards; Pharmaceutical Preparation Manufacturing (NAICS) dominates with 35 awards, with Drugs and Druggists' Sundries Merchant Wholesalers covering 10 additional awards.

Activity has grown markedly in 2025 and early 2026, rising from one award in 2021 to twenty-eight awards in 2025 and ten awards in 2026 year-to-date. Combined potential value across all forty-seven awards totals $1.3 million, with $1.2 million obligated (97 percent of potential value), reflecting near-complete execution on firm fixed-price pharmaceutical supply contracts. Only two awards (combined potential value $76 thousand) carry ultimate completion dates within the next twenty-four months and therefore face recompete exposure.

Quick answers

What is Pantherx Specialty, LLC's UEI?

Pantherx Specialty, LLC's Unique Entity ID (UEI) in SAM.gov is EG8MVF1BJ9H6.

What is Pantherx Specialty, LLC's CAGE code?

Pantherx Specialty, LLC's CAGE code is 82BT8.

What is Pantherx Specialty, LLC's primary NAICS code?

Pantherx Specialty, LLC's primary NAICS code is 456110 (Pharmacies and Drug Retailers).

Where is Pantherx Specialty, LLC located?

Pantherx Specialty, LLC's physical address in SAM.gov is 121 Bayer Rd Bldg 5, Pittsburgh, PA 15205, USA.

Is Pantherx Specialty, LLC registered in SAM.gov?

Yes. Pantherx Specialty, LLC's SAM.gov registration is active through February 2, 2027.

What is Pantherx Specialty, LLC's most recent federal award?

Pantherx Specialty, LLC's most recent federal contract award is Yorvipath medication for inmates (15B10626P00000346), from Federal Correctional Complex Butner, on August 1, 2026.

On GovTribe

See Pantherx Specialty, LLC's full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors